To Explore the Changes of Nutritional Status, Immune Function, Intestinal Motility and Intestinal Flora in Patients With Constipation Before and After Surgical Treatment
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05983926 |
Recruitment Status :
Completed
First Posted : August 9, 2023
Last Update Posted : August 14, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Constipation Surgical Treatment | Procedure: Subtotal colectomy was performed | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 60 participants |
Allocation: | N/A |
Intervention Model: | Sequential Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | The Intestinal Motility, Nutritional Status, Immune Function and Intestinal Environment of Patients Were Evaluated by Measuring BMI, Biochemical Tests and Nutritional Risk Related Questionnaires |
Actual Study Start Date : | January 1, 2020 |
Actual Primary Completion Date : | March 31, 2023 |
Actual Study Completion Date : | June 30, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: Differences in conditions before and after surgical treatment of constipation |
Procedure: Subtotal colectomy was performed
Colonic subtotal resection, also known as subtotal colectomy, is a surgical procedure used to treat colonic diseases such asconstipation, colon cancer, ulcerative colitis, and others. The purpose of this surgery is to remove a portion of the colon in the patient's body. Unlike a total colectomy, which involves removing the entire colon, a subtotal colectomy only removes a portion of the colon. The procedure typically involves removing the diseased part of the colon and reconnecting the remaining colon. This allows for the preservation of some normal colonic function, enabling the patient to have regular bowel movements. |
- The nutritional status of the patients was assessed according to the scores of nutritional risk screening and assessment tool Nutritional Risk Screening2022(NRS2002) [ Time Frame: Baseline and 6 months after surgery ]The full length of NRS2002 is called Nutritional Risk Screening2022. The minimum score is 0 and the maximum score is 3, with higher scores indicating higher nutritional risk.
- The nutritional status of the patients was assessed according to the scores of nutritional risk screening and assessment tool Malnutrition Universal Screening Tool (MUST). [ Time Frame: Baseline and 6 months after surgery ]The full name of MUST is Malnutrition Universal Screening Tool, score 0: low risk; Score 1: moderate risk; A score of 2 or higher is considered high risk.
- The nutritional status of the patients was assessed according to the scores of nutritional risk screening and assessment tool Mini Nutritional Assessment (MNA). [ Time Frame: Baseline and 6 months after surgery ]Mini Nutritional Assessment (MNA) is defined as "good nutritional status" when MNA≥24. 17≤MNA < 24, nutritional risk; MNA < 17 indicated malnutrition.
- The peristalsis status of patients was evaluated according to the frequency of defecation and the character of feces. [ Time Frame: Baseline and 6 months after surgery ]
- The changes of fecal microbiota were detected by 16SDNA sequencing. [ Time Frame: Baseline and 6 months after surgery ]
- Quantitative changes in immune cells were determined by flow cytometry of blood samples. [ Time Frame: Baseline and 6 months after surgery ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Disease duration more than 6 years;
- Wexner constipation score >15;
- No response to medical treatment, biofeedback and fecal microbiota transplantation;
- according to the surgical indications;
- All patients were informed of this study and signed the informed consent.
Exclusion Criteria:
- Suffering from mental disorders or cognitive impairment;
- With malignant tumors; -
- With history of gastrointestinal surgery;
- Complicated with other organ dysfunction;
- With immune system diseases.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05983926
China, Shanghai | |
Shanghai Tenth People's Hospital | |
Shanghai, Shanghai, China, 200071 |
Principal Investigator: | Le Wang, Master | Intestinal Microenvironment Treatment Center of General Surgery, Shanghai Tenth People's Hospital, Tenth People's Hospital of Tongji University |
Responsible Party: | Huanlong Qin, Clinical Professor, Shanghai 10th People's Hospital |
ClinicalTrials.gov Identifier: | NCT05983926 |
Other Study ID Numbers: |
STC-20230704 |
First Posted: | August 9, 2023 Key Record Dates |
Last Update Posted: | August 14, 2023 |
Last Verified: | August 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Constipation Signs and Symptoms, Digestive |